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ABSTRACT OF THESIS

LOSS AVERSION IN COCAINE USERS:
INFLUENCE OF RISK AND COMMODITY TYPE
Numerous studies in behavioral economics have demonstrated that individuals are
more sensitive to the prospect of a loss than a gain (i.e., loss aversion). Although loss
aversion has been well described in healthy populations, little research exists in
individuals with substance use disorders. The purpose of this study was to
comprehensively evaluate loss aversion in cocaine users. Participants completed
measures designed to assess loss aversion for drug and non-drug commodities under
varying risk conditions. Cocaine demand was determined using a cocaine purchase
task. Cocaine users showed a loss aversion score that was consistent across
commodity and risk conditions. Compared to the normative loss aversion coefficient
value (i.e., λ = 2) a large effect size decrease in loss aversion was observed in cocaine
users. Hypothetical demand for cocaine was well explained by demand models. More
intense and inelastic cocaine demand was also associated with greater loss aversion for
cocaine. These data represent the first systematic study on loss aversion in cocaine
using populations and indicate that reduced loss aversion is associated with cocaine
use. Future studies should explore potential behavioral and neurobiological mechanisms
to determine the benefit of loss aversion for treatment and intervention development
efforts.
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Chapter 1: Introduction
Substance use disorders present a persistent public health concern, with the annual
economic impact of illicit drug use estimated at $193 billion in the United States (United
States Department of Justice, 2011). The most recent National Survey on Drug Use and
Health (NSDUH) indicates that nearly 1.5 million persons aged 12 or over were current
cocaine users and over half of those individuals met diagnostic criteria for a cocaine use
disorder (Center for Behavioral Health Statistics, 2015). Other sources indicate that the
NSDUH may underestimate the prevalence of active cocaine use, and that as many as
3.9 million individuals use cocaine four or more times per month (Caulkins, Kilmer,
Reuter, & Midgette, 2014). Cocaine use poses a particularly salient concern due to the
relative lack of effective behavioral and pharmacological treatments for those seeking
abstinence. Despite sustained efforts at identifying behavioral interventions and
pharmacotherapies for cocaine use disorder, few effective treatments exist, and those
that do suffer from selective effects, low retention, and high relapse rates (Dutra et al.,
2008; Stoops & Rush, 2013).
Many of the diagnostic criteria for cocaine and other substance use disorders are
defined by behaviors relevant to choice and decision-making. In the most recent edition
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) cocaine use
disorder is diagnosed based on criteria including: an individual’s use of more cocaine
than intended; unsuccessful efforts to control cocaine use; spending a large amount of
time finding, using, or recovering from the effects of cocaine; using cocaine to the
exclusion of other activities; continued use of cocaine despite problems caused by use;
and use of cocaine in dangerous situations (American Psychiatric Association, 2013).
Understanding how maladaptive patterns of choice develop and persist in substance use
disorders is critical to identifying mechanisms of disease etiology and advancing
intervention design.
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Behavioral economics is the field of economics that characterizes choice and
decision-making under conditions of constraint and attempts to explain departures from
classic economic theory and decisions based on expected utility. Behavioral economic
theorists posit that suboptimal behavior is a consequence of systematic choice biases
that depart from traditional economic decisions (i.e., expected utility decisions). The
recent application of behavioral economic principles to substance use research has
resulted in exciting advances in both theoretical and empirical domains (Chivers &
Higgins, 2012). For example, research on delay discounting has improved the field’s
understanding of the etiology and treatment of substance use disorders. Delay or
temporal discounting refers to the systematic reduction in the value of reinforcers as a
function of delay to reinforcer delivery (Rachlin & Green, 1972). Numerous studies have
demonstrated excessive discounting of delayed reinforcers in substance using
populations, and the knowledge of this systematic bias has helped guide recent
intervention efforts (e.g., as a putative moderator of treatment efficacy) (Bickel,
Jarmolowicz, Mueller, Koffarnus, & Gatchalian, 2012; Washio et al., 2011). Exploration
of other, understudied mechanisms of disordered choice could also result in significant
research gains.
Loss aversion is a choice bias that has received a great deal of attention in the
behavioral economic literature (Novemsky & Kahneman, 2005). Numerous studies have
demonstrated that, all things being equal, losses tend to have a greater impact on
behavior than gains (Kahneman & Tversky, 1979; Tversky & Kahneman, 1991, 1992).
For example, an individual receiving a $20 parking fine will report a greater magnitude
impact on behavior than an individual winning a $20 bet. This idea that losses loom
larger than gains is used to explain a range of behavioral phenomena, such as the
endowment effect (i.e., that individuals will sell a good for on average twice as much as
they are willing to pay for the same good) (Rick, 2011). Despite the prevalence of
2

research exploring loss aversion in traditional economic contexts, little research exists
that focuses on clinical populations. Even less attention has been paid to understanding
loss aversion in substance using populations. The results of a PubMed search using the
keywords “loss aversion” AND “drug” reveals only 17 papers, six of which are literature
reviews. Investigating loss aversion in active substance users may provide critical insight
into the etiology of substance use disorders and treatments targeting the suboptimal
choices characteristic of drug use.
Prospect Theory and Loss Aversion
Prospect theory is a seminal model in behavioral economics used to explain choice
in situations of risk, loss, and uncertainty (Kahneman & Tversky, 1979; Tversky &
Kahneman, 1992). Central to prospect theory is the notion that behavioral preference is
not determined by the final outcome of a choice, but instead, by the change relative to a
reference point. In this way, it is not that a bank account might have changed by $50; it
is whether this change was a gain or a loss that determines the relative impact. Value,
then, is not an objective constant and is influenced by the relative reference point of a
decision and its consequence.
A key phenomenon explained by prospect theory is loss aversion. As described
above, all things being equal, people are more sensitive to the prospect of losing a
commodity than the prospect of gaining an equally valued commodity. Prospect theory
predicts that receiving a $500 raise would produce a smaller magnitude positive impact
than the negative impact of a $500 pay cut. Whereas when an employee that receives a
raise might feel pleased and enthusiastic, if she were to receive a cut in pay, she might
be deeply outraged or saddened. Although in both instances the objective value of the
change is equal, the reference point differs. Thus, at the broadest level, prospect theory
and loss aversion suggest that the framing of an outcome as a loss or gain is a critical
determinant of behavior, choice, and affective impact.
3

Mathematical models and behavioral measures of loss aversion are often used to
quantify the relative impact of losses as compared to gains. The ratio comparing the
relative value of avoiding losses to the pursuit of gains is described by the loss aversion
coefficient, lambda (λ). Numerous studies have demonstrated that in the general
population λ is approximately equal to 2 (Novemsky & Kahneman, 2005). This value
suggests a 2:1 ratio of loss to gain, or that the impact of a loss is approximately twice
that of an equivalent gain. This value also indicates that a gain must be twice the value
of a loss to be of equal utility. Returning to the example of the disgruntled employee,
only if her raise were $1000 would it be subjectively equal to a $500 cut in pay.
Loss aversion occurs under both conditions of certainty (i.e., riskless) and risk
regarding the outcome of that choice. Riskless choice refers to situations of certain
outcome, such as buying or selling a commodity for a pre-determined price (Tversky &
Kahneman, 1991). Loss aversion in this context is the behavioral mechanism used to
explain the endowment effect wherein an individual will request on average twice as
much to sell a commodity as he or she is willing to pay for that same good (Novemsky &
Kahneman, 2005). For example, an employee may want a chocolate bar and be willing
to buy it from a vending machine for $1.00. But if that employee’s friend also wanted a
chocolate bar and decided to buy it from her, loss aversion and the endowment effect
would predict that she would request at least $2.00 to sell her chocolate bar.
Risky choice occurs during decisions of probability or chance (e.g., when making a
gamble). Loss aversion in this context denotes disfavor of gambles with possible losses.
The commonly confused phenomenon of risk aversion refers to a more general aversion
towards outcome variability, regardless of whether that outcome is a loss or a gain.
Individuals are more likely to reject gambles of positive expected value if the potential for
loss is up to half as much as the expected gain (Tom, Fox, Trepel, & Poldrack, 2007).
For example, if the employee decided to make some cash on the side and started
4

betting on coin flips with her coworkers, it is unlikely that she would accept gamble if the
consequence was “heads you win $10 and tails you lose $10.” Even if the payoffs were
a $10 gain for heads and a $6 loss for tails, she would still be unlikely to accept the bet.
Only when the possible gain was twice or more the possible loss would she likely accept
(e.g., $10 win to $5 loss).
Although choice under certainty and under risk may present as qualitatively different
conditions, the quantitative expression of loss aversion is similar. Both risky and riskless
conditions produce loss aversion and result in loss aversion coefficients of approximately
2 (Novemsky & Kahneman, 2005; Tom et al., 2007). The similarity in these experimental
outcomes is suggestive of a common behavioral mechanism underlying choice.
However, few studies have examined the relationship among behavioral measures of
loss aversion using within-subjects manipulations. Those studies that do exist suggest
that loss aversion is consistent across conditions of certainty and risk (Gachter,
Johnson, & Herrmann, 2007). Additional research that directly compares behavioral
measures of loss aversion under certainty and risk is needed.
Measures of Loss Aversion
Loss aversion has received a great deal of attention in the behavioral economic
literature, with numerous studies demonstrating a robust and reliable avoidance of
losses relative to pursuit of gains under certain and risky conditions. A number of
behavioral tasks have been developed that quantitatively measure loss aversion. Many
of these tasks define loss aversion by using a standardized loss aversion coefficient (i.e.,
λ) allowing for comparisons across studies and populations.
One of the most popular tasks used to examine loss aversion is the valuation task
(Kahneman, Knetsch, & Thaler, 1990). The valuation task is a measure of loss aversion
under certain conditions. In the original version of this task, participants were randomly
divided into a “buy” or “sell” group. Participants in the “buy” group were shown a
5

commodity (i.e., a coffee mug) and asked the maximum amount of money they were
willing to spend to buy the mug. Participants in the “sell” group were given the same
commodity and asked the minimum amount of money they were willing to sell the mug
for. The ratio of sell to buy (or “Willingness-to-Accept to Wiliness-to-Purchase”;
WTA:WTP) provides a behavioral index of loss aversion.
In one of the earliest studies, students from a business statistics class were
randomly selected to be buyers or sellers of a coffee mug (Kahneman et al., 1990).
Participants were allowed to choose to buy (or sell) at prices ranging from $0.00 to $9.50
in $0.50 intervals. Sellers in that study requested nearly double the median price
compared to buyers, concordant with predictions from prospect theory (medians = $5.75
to $2.21; λ = 2.6). Since then, numerous studies have replicated this finding across
commodities (e.g., pens, orange juice, etc.) and shown sensitivity to experimental
manipulations such as time (e.g., length of ownership) and likelihood of trading the
commodity in the future (see reviews by Morewedge & Giblin 2015; Novemsky &
Kahneman, 2005). For example, a short expected length of ownership attenuates the
WTA to WTP gap, whereas decreasing the opportunity to trade or sell the good at a later
date enhances this gap.
More varied behavioral measures of loss aversion exist for conditions of risky choice.
One popular method for examining deficits in decision-making is the Iowa Gambling
Task (IGT; Bechara, Damasio, Damasio, & Anderson, 1994; Bechara et al., 2001). In the
IGT, participants make a series of choices from four decks of cards in which every
choice results in a gain that is sometimes coupled with a simultaneous loss. Selections
from two disadvantageous decks results in a net loss, whereas selections from two
advantageous decks results in a net gain. In the original demonstrations of the IGT,
participants with ventromedial prefrontal cortex damage showed poor performance
attributed to an indifference for long-term consequences (Bechara, Damasio, Tranel, &
6

Damasio, 1997). A number of investigators have used the IGT in the context of loss
aversion and attributed poor performance to deficits in the anticipation of long-term
consequences for disadvantageous decks, hypersensitivity to rewards, and/or
hyposensitivity to losses (e.g., Ahn et al., 2014).
A distinct limitation of the IGT is the difficulty in distinguishing the relative contribution
of loss aversion from the inability to learn from feedback. One solution is the use of
mathematical modeling to decompose IGT behavioral performance into distinct
behavioral constructs. For example, the Prospect Valence Learning (PVL) model divides
performance into four constructs: 1) loss aversion (λ), 2) reward sensitivity (α), 3)
recency (A), and 4) consistency (c) (Ahn, Busemeyer, Wagenmakers, & Stout, 2008;
Fridberg et al., 2010; Vassileva et al., 2013). Alternatively, the Expectancy Valence
(EVL) model divides performance into three constructs: 1) motivation (responsiveness to
risk), 2) learning/memory (updating expectancies about the value of risky alternatives),
and 3)

sensitivity/consistency (trial-by-trial matching with expected outcomes)

(Busemeyer & Stout, 2002; Lane, Yechiam, & Busemeyer, 2006; Stout, Busemeyer, Lin,
Grant, & Bonson, 2004). The use of mathematical modeling has provided evidence of
differential loss aversion in various clinical populations (Ahn et al., 2014; Busemeyer &
Stout, 2002; Fridberg et al., 2010; see below for more detail).
A popular alternative to the IGT, particularly in the economic literature, is the mixed
gambles task. Participants in this task are asked to accept or reject gambles of varying
probabilities and varying loss-to-gain magnitudes. Although variations in the task may
alter the specific probabilities, magnitudes, and choice types (e.g., Gamble #1 versus
Gamble #2, Gamble versus No Gamble), these measures have consistently
demonstrated loss aversion in the general population. In one of the most popular
versions of the mixed gambles task, participants decide whether to accept or reject
50/50 bets (i.e., coin flips) with varying magnitude gains and losses (Tom et al., 2007).
7

Individuals on this task are more likely to reject gambles in which the possible gain is
less than double the possible loss, which is consistent with other measures of loss
aversion. For example, a wager with a possible gain of $50 is typically rejected if the
possible loss is $25 or more. A major benefit of the mixed gambles task is that skill and
prior learning do not mediate performance, unlike the IGT. Because gamble results are
not displayed throughout the task (i.e., the participant is blind to gamble outcomes),
feedback-based responding also does not influence behavior.
Loss Aversion in Clinical Populations
Few studies have examined loss aversion in clinical populations and even fewer
have examined individuals with substance use disorders. Attenuated loss aversion has
been observed in individuals with schizophrenia under both riskless and risky conditions
(Brown et al., 2013; Tremeau et al., 2008). Patients with schizophrenia in one of these
studies failed to show loss aversion in a valuation task and demonstrated higher
requested prices as buyers than as sellers (λ = 0.87; Tremeau et al., 2008). Loss
aversion coefficients in that study correlated with duration of illness, but not measures of
current psychopathology. This finding suggests that altered loss aversion may be a
consequence of sustained behavioral and/or biological changes over disease course
rather than a function of acute symptomology. Similarly, under conditions of risk,
individuals with schizophrenia show deviations from normal decision-making and an
impaired assessment of expected value (Brown et al. 2013). In contrast to these
findings, patients with depression show enhanced loss aversion relative to control
groups (Chandrasekhar Pammi et al. 2015). Performance on a mixed gambles task in
that study indicated higher loss aversion coefficients in depressed patients. Furthermore,
activity in regions of the midbrain and ventral tegmental area were associated with these
enhanced λ values. These findings are notable given that a previous neuroimaging study
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in healthy controls also implicated regions of the mesolimbic and mesocortical dopamine
systems in loss aversion (Tom et al., 2007).
A series of studies has examined loss aversion in problem gamblers and revealed
mixed findings. One of these studies found attenuated loss aversion in gamblers in
outpatient treatment that performed the IGT and a mixed gambles task (Lorains et al.
2014). In contrast, another study found that problem gamblers undergoing treatment
showed enhanced loss aversion that corresponded with the stage of treatment (i.e.,
higher loss aversion in later-stage treatment; Giorgetta et al. 2014). In another study,
poorer performance on a mixed gambles task and the IGT was observed in nontreatment seeking gamblers (Brevers et al. 2012). Although that study did not directly
compute a loss aversion coefficient, performance was consistent with attenuated loss
aversion. Taken together, these findings support the notion that loss aversion may relate
to and be altered by treatment status in problem gamblers.
Loss Aversion in Substance Using Populations
Little research has evaluated loss aversion in substance using populations and the
research that exists has focused on risky loss aversion. A majority of these studies have
used the IGT in combination with various computational models in order to isolate
behavioral constructs of loss aversion. Few studies exist in substance using populations
utilizing mixed gambles tasks, and none have compared loss aversion under certainty
and risk by using a within-subjects design.
The acute effects of drugs on loss aversion have been examined in two studies
(George, Rogers, & Duka, 2005; Lane et al., 2006). In the first of these studies,
participants were administered alcohol (0.6 g/kg) or placebo and asked to perform a
mixed gambles task (George et al., 2005). Gambles in this task varied in loss and gain
magnitude as well as in probability. Acute alcohol produced an impaired assessment of
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gain magnitude and probability. Importantly, no differences in reaction time were
observed suggesting that these effects were not due to general motor impairment.
The second of these studies was a retrospective analysis of data from studies
evaluating the acute effects of alcohol, cannabis, and alprazolam (Lane et al., 2006). All
included studies used an experimenter-designed risk-taking task in which participants
chose between a non-risky, low payoff and risky, high payoff option. These data were
examined using the EVL model providing measures of reward responsiveness, learning,
and outcomes sensitivity. Acute alcohol (0.8 g/kg) produced a heightened sensitivity to
rewards and/or decreased sensitivity to losses, but did not change learning from
previous outcomes and response sensitivity. In contrast, acute cannabis (3.58%)
impaired learning and sensitivity to outcomes, but produced no changes in valence
sensitivity. Finally, alprazolam (2 mg) administration only impaired learning from
previous outcomes and did not affect valence or response sensitivity. Important to note
is that these acute drug effect studies were conducted in social drinkers and student
populations. It remains unknown if the reported acute effects of drugs on loss aversion
would extend to individuals with substance use disorders.
One study examined abstinent amphetamine- and heroin-dependent individuals
performing the IGT whose performance was analyzed using a variety of computational
models (Ahn et al., 2014). These participants were in extended abstinence, with at least
a three-month period since the last reported drug use. Abstinent heroin users in that
study showed attenuated loss aversion relative to healthy controls. Amphetaminedependent individuals, in contrast, showed increased reward sensitivity, but not
attenuated loss aversion relative to controls. These findings indicate that particular
decision-making deficits may remain during abstinence, and that these deficits may differ
as a function of abused substance.
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One study has examined loss aversion in chronic cannabis users (Fridberg et al.,
2010). These investigators found that the PVL model provided the best fit to the
experimental outcomes and that attenuated loss aversion on the IGT was observed in
cannabis users relative to matched controls. These findings indicated that cannabis
users treated loss as constant and of relatively minor impact regardless of loss
magnitude. Additionally, decisions made by cannabis users showed inconsistency with
respect to expected outcomes suggesting an impaired computation of expected value.
A number of studies have demonstrated impaired performance by active cocaine
users on the IGT (e.g., Balconi, Finocchiaro, & Campanella, 2014; Hulka et al., 2014;
Stout et al., 2004). In one such study, male cocaine users completed the IGT and
parameters from computational models were compared to matched controls (Stout et al.,
2004). These individuals showed an impaired risk responsiveness resulting in attenuated
sensitivity to losses and/or an enhanced sensitivity to gains. Furthermore, cocaine users
showed impaired sensitivity to expected value and greater randomness in choice (i.e.,
non-concordant with expected value). Although no direct measures of loss aversion
were computed, these findings are suggestive of an attenuation of loss aversion in
cocaine-using populations.
Another study examined women enrolled in a longitudinal study on HIV (Vassileva et
al., 2013). A subset of these women reported a history of illicit drug use, including heroin
and/or cocaine use. In that study, participants completed the IGT and parameter values
were compared using the PVL computational model. Drug use was associated with
decreases in loss aversion and impaired learning from feedback and HIV+ status with
reductions in loss aversion. However, only 14% of the women in the drug-use condition
reported current cocaine use, making inferences about the specific role of active cocaine
use on loss aversion difficult.
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In contrast to these other studies, data obtained in HIV-positive cocaine users
suggests enhanced loss aversion (Meade, Young, Mullette-Gillman, Huettel, & Towe,
2014). Participants in that study performed a mixed gambles task and completed
measures of substance use and sexual risk taking. Individuals with active cocaine use
reported greater loss aversion than those that did not, and within this group, loss
aversion was positively associated with sexual risk behavior and missing medication
appointments. It is important to note that these data were presented at the 2014 annual
meeting of the College on Problems of Drug Dependence and have not been published
in a peer-reviewed format. It is also unclear if these results are a function of cocaine use,
HIV status, or a unique combination of the two. Investigating the specific role of active
cocaine use in expression of loss aversion will be crucial for clarifying these
discrepancies.
The reviewed literature suggests that drug use is related to deviations in expected
value computation and loss aversion. These collective findings indicate that the use of
drugs from multiple classes, including cannabis, opioids, and psychomotor stimulants, is
associated with decreases in loss aversion. Additional research is needed, however, to
clarify discrepancies observed in some studies (e.g., Meade et al. 2014) and to
understand the cross-context consistency of loss aversion through the use of multimethod, within-subjects techniques.
Implications of Loss Aversion for Substance Use Disorders
Loss aversion could play a role in the etiology and persistence of substance use
behaviors. Maladaptive patterns of drug taking maintained by the inability to adequately
assess losses and gains and a consequent over- or undervaluation of negative
consequences (e.g., withdrawal, unemployment) would likely result in the enduring drug
use phenotypes often observed in the clinical setting. Loss aversion may also relate to
clinical status as observed in problem gamblers. If this is true, loss aversion could
12

provide a behavioral marker

for substance use diagnosis and assessment.

Demonstrating that loss aversion correlates with the clinical expression of cocaine use
would be essential for demonstrating a causal role in the clinical condition, rather than as
an epiphenomenon of the disorder.
Examining loss aversion in substance using populations may also be important for
intervention design. In particular, loss aversion has a substantive relationship to
outcomes in contingency management (CM). Differences in loss aversion could
potentially affect the subjective impact of monetary incentives when framed as gains as
opposed to losses (e.g., “contract-base” CM). Evidence from smoking CM interventions
suggests that loss-framed incentives differentially motivate abstinence initiation, whereas
gain-framed incentives help to sustain abstinence (Romanowich & Lamb, 2013).
Assessing sensitivity to loss aversion could provide a putative moderator of CM efficacy
and contribute to patient-level tailoring of CM design.
It is unknown how loss aversion might relate to drug-taking behaviors. The recent
development of self-reported purchase tasks to measure economic demand for drugs
and other commodities provides a simple method to measure this relationship (e.g.,
Amlung, McCarty, Morris, Tsai, & McCarthy, 2015; MacKillop et al., 2008; Murphy &
MacKillop, 2006). Participants are asked on these tasks to report consumption of
specific commodities (e.g., cocaine) across changes in price. Transformation of the
price-level consumption into demand curves allows for the mathematical modeling of
demand parameters, such as intensity (Q 0; consumption at zero cost) and elasticity (α; a
measure of the change in consumption with change in unit price). Additional parameters
may also be generated from the raw demand curve (e.g., breakpoint or the point where
consumption drops to zero). Demand curves, then, provide the benefit over traditional
measures of drug reinforcement (e.g., response rate) of effectively and efficiently
isolating several behavioral mechanisms of drug use.
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A majority of research on drug purchase tasks has examined alcohol and nicotine
consumption (e.g., Murphy, MacKillop, Skidmore, & Pederson, 2009; MacKillop et al.,
2008, 2012). Our laboratory has recently developed a cocaine purchase task modified
from previous literature (Bruner & Johnson, 2014) and demonstrated reliable outcomes
and correspondence between cocaine demand parameters and cocaine use variables
(Stoops et al., 2016; Strickland, Lile, Rush, and Stoops, in press; Strickland, Reynolds, &
Stoops, in press). The use of a cocaine purchase task in conjunction with measures of
loss aversion will allow for the rapid and efficient study of the relationship between these
behavioral economic outcomes.
Summary and Purpose
Loss aversion refers to the general tendency for losses to have a greater impact on
behavior than equal magnitude gains. Behavioral economics suggests a number of
contexts in which loss aversion is expressed, including under conditions of certainty and
risk regarding the outcome of choice. Far less is known about loss aversion in substance
using populations. The available literature suggests that clinically relevant drug use is
associated with diminished loss aversion relative to normative populations. More
information is necessary to clarify discrepant results, evaluate the relationship between
loss aversion and behavioral mechanisms of drug use, and examine the cross-context
consistency of loss aversion through the use of multi-method, within-subjects
techniques.
The primary purpose of this study was to examine loss aversion in active
cocaine users. Loss aversion was evaluated using a multi-method test battery that
varied in the level of risk present and the commodity available. Loss aversion under
riskless contexts was assessed using a valuation task and loss aversion under risky
contexts assessed using a mixed gambles task. Although previous research supports a
correspondence between loss aversion under certainty and risk (Gachter et al., 2007), it
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is unknown if this relationship holds in drug-using populations. The commodity available
was manipulated in order to evaluate potential differences in loss aversion for drug (i.e.,
cocaine) and non-drug (e.g., money) outcomes. A risk aversion task was also included
to determine the specific contribution of loss aversion over more general aversion to
uncertain outcomes.
It was hypothesized that loss aversion would deviate from normative values (i.e., λ =
~2) in active cocaine users. Given the discrepancies reported in prior research, no
directional hypothesis was made about this deviation. It was also expected that risky and
riskless loss aversion would correlate in active cocaine users, concordant with the
relationship observed in the general population. Finally, loss aversion was predicted to
be greater for drug than for non-drug commodities.
A secondary aim was to evaluate the relationship between loss aversion and
behavioral mechanisms of drug use. A cocaine purchase task was used to isolate
behavioral mechanisms of cocaine demand and determine the association between loss
aversion and cocaine demand. Additional analyses were conducted to identify individual
differences in loss aversion as a function of other cocaine use variables (e.g., monthly
cocaine use) and demographics (e.g., age, sex).
Cocaine demand was predicted to decrease as a function of price and be well
explained by the exponentiated demand equation. It was also expected that intensity of
demand would positively and elasticity of demand negatively correlate with cocaine use
variables (e.g., frequency of current cocaine use, lifetime cocaine use), further validating
the cocaine purchase task. Loss aversion coefficients were anticipated to correlate with
intensity of demand and elasticity of demand, although a directional hypothesis was not
made for reasons stated above.
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Chapter 2: Methods
Participants
A total of 38 participants (22 male; 16 female) provided sober, written informed
consent to participate in this within-subjects, outpatient study. All potential participants
underwent a comprehensive screening process (Stoops, Lile, & Rush, 2010). The
screening procedure included series of health, psychiatric, and drug use history
questionnaires including: the Beck Depression Inventory, Brief Symptom Index, and
assessments for ADHD, mental status, and drug and alcohol use disorders. Drug use
histories (e.g., time since first use, frequency and quantity of current use, and times used
over lifetime) were collected for amphetamines, barbiturates, benzodiazepines,
cannabis, cocaine, hallucinogens, inhalants, and opioids. Standardized drug use
questionnaires included the Drug Abuse Screening Test (DAST), Fagerström Test for
Nicotine Dependence (FTND), and the Michigan Alcohol Screening Test (MAST).
Participants also completed the impulsivity subscale of the Zuckerman-Kuhlman
Personality Questionnaire (ZKPQ). Diagnostic criteria for Cocaine Abuse or Dependence
were assessed using the computerized Structured Clinical Interview for DSM-IV (SCID),
but presence of a cocaine use disorder was not an inclusion criterion to allow cocaine
use behaviors to freely vary. Participants were excluded if they endorsed a history of
serious physical disease, current centrally acting medication, or current or past histories
of serious psychiatric disorder that would interfere with study participation. Participants
with a history of a substance use disorder that was deemed to interfere with study
completion (e.g., physiologic alcohol dependence) were also excluded.
Participants were English-speaking, English-reading, and 18 years of age or older.
The sample was generally male (58%) and African American (82%) with a high school or
certification-equivalent education (e.g., GED). All participants reported recent cocaine
use verified by a cocaine- or benzoylecgonine-positive urine sample. Most participants
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reported an extensive history of cocaine use (interquartile range [IQR] = 16 to 26 years)
and a majority met criteria for a cocaine use disorder (94.7%). Demographic and selfreported drug use variables are presented in Table 2.1.
Participants were told that the purpose of the study was to learn about how people
make decisions. Other than this general explanation of purpose, participants were not
given any information concerning what outcomes might be expected. The study was
conducted in accordance with all relevant guidelines, including the Declaration of
Helsinki, and approved by the Medical Institutional Review Board of the University of
Kentucky.
General Procedure
This within-subjects, outpatient study consisted of one session and took
approximately one to two hours for each participant to complete. The session took place
during screening for other outpatient and inpatient protocols at the University of
Kentucky Laboratory of Human Behavioral Pharmacology (LHBP). Participants that met
the eligibility criteria above came to the LHBP, underwent a field sobriety test, and
provided an expired air sample that was required to be negative for alcohol. Participants
were also required to provide a urine specimen that was tested for recent use of
amphetamine, benzodiazepines, barbiturates, cocaine, tetrahydrocannabinol (THC), and
opioids. This specimen had to be negative for all substances except cocaine to
participate in the experimental protocol that day. Sessions could proceed with a THC
positive specimen, but the participant had to pass a standard field sobriety test to ensure
they were not acutely intoxicated.
Payment Schedule
Participants were provided $30 for use in behavioral tasks and told that they could
use this money for purchasing items and making gambles. They were also told that their
compensation would vary depending on task performance, but that the total amount
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earned would not be less than $0 (i.e., they would not owe the experimenters money). In
actuality, all participants earned $10 for the mixed gambles and risk aversion tasks (see
below) for a maximum compensation of $60 dependent on valuation task choice
(valuation task commodities received + $20 to $60 task compensation).
Behavioral Measures and Task Analyses
Valuation Task: Loss Aversion Under Certainty. A valuation task was used to
determine loss aversion under certainty (Gachter et al., 2007; Kahneman et al., 1990). In
the “Willingness-to-Accept” (WTA) condition, participants were given a commodity (e.g.,
coffee mug) and told they could keep it. Participants were then asked to indicate the
price(s) at which they would be willing to sell the commodity. Prices varied from $0.50 to
$10.00 in $0.50 increments for non-drug commodities. The “Willingness-to-Purchase”
(WTP) condition was identical except that participants were shown the commodity and
told they had the opportunity to purchase it. Participants were then asked to indicate at
each price whether they were prepared to buy the commodity. Although valuation tasks
have typically used a coffee mug as the commodity, the current study also used
headphones given that pilot testing indicated that participants considered headphones
an ecological relevant commodity. Participants were told that one price point from the
task would be randomly selected and the decision carried out (e.g., receipt of the good
or money) to encourage active participation. A novel cocaine valuation task was also
used to assess loss aversion for drug commodities. Participants were asked to make
hypothetical decisions about purchasing or selling 1 g of cocaine for prices ranging from
$10 to $200 in $10 increments. All other procedures were identical to the traditional
valuation task.
Headphone, mug, and cocaine valuation tasks were presented in a randomized
order. Presentation order for the WTA and WTP conditions was also counterbalanced
across participants with approximately 30 minutes between tasks to avoid carryover
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effects. The primary outcome from the valuation task was the ratio of WTA/WTP that
provides a standardized measure of loss aversion (i.e., λ). Previous research indicates
normative values for λ of approximately 2, indicating that individuals will typically ask for
twice the amount to sell than they will to purchase the same commodity (Kahneman et
al., 1990; Novemsky & Kahneman, 2005).
Mixed Gambles Task: Loss Aversion Under Risk. A mixed gambles task (i.e., coin
flip task) was used to determine loss aversion under risk (Tom et al., 2007). Participants
were asked to accept or reject gambles offering a 50/50 chance of winning or losing
variable amounts of money. Gains ranged from $10 to $40 in increments of $2, whereas
losses ranged from $5 to $20 in increments of $1. These ranges were selected to
produce a range of gambles that could account for an approximate two-fold difference in
sensitivity to loss versus gain (λ = 2) and to be consistent with previous uses of the task.
All 256 possible combinations of gains and losses were presented in a randomized
order. Participants were told to respond carefully because one trial would be chosen at
random and compensation provided based on that trial. However, as indicated above, all
participants were paid $10 for participation in the mixed gamble and risk aversion tasks.
The primary outcome from this task was λ, calculated as λ = -βloss /βgain derived from the
logistic regression of 1) gain magnitude and 2) loss magnitude on trial choice (i.e.,
accept versus reject as the criterion). Participants were excluded if the logistic
regression model could not converge or when the validity of the model fit was in question
(e.g., complete or quasi-complete separation). Nine participants were excluded from one
or more mixed gambles analyses because their choices did not allow for generation of
accurate λ terms using logistic regression (Money Task Only = 2; Cocaine Task Only =
4; Both Tasks = 3). In general, this reflected a propensity to accept too many gambles
(e.g., all gambles), such that generation of logistic regression coefficient terms was not
accurate.
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Risk Aversion Task. A risk aversion task was used to assess general aversion
towards outcome variability (De Martino, Camerer, & Adolphs, 2010). Participants were
presented with double or nothing gambles. The task consisted of 11 trials and included
the following monetary values: $2, 5, 10, 15, 20, 25, 30, 35, 40, 45, and 50. Participants
were told to respond carefully because one trial would be chosen at random and
compensation provided based on that trial. However, as indicated above, all participants
were paid $10 for participation in the mixed gamble and risk aversion tasks. The primary
outcome from the risk aversion task was the number of gambles accepted. Previous
studies of loss aversion have used this measure to account for general distaste for risk
over a specific aversion to loss (De Martino et al., 2010).
Cocaine Purchase Task. A cocaine purchase task was used to assess economic
demand for cocaine (Stoops et al., 2016). Participants were asked to indicate the
hypothetical number of cocaine “hits” (i.e., 0.1 g cocaine units) they would purchase at
16 monetary increments ranging from $0.00 [free] to $1000 per 0.1 g. All choices were
hypothetical and were not purchased or administered. Data from the cocaine purchase
task were analyzed using nonlinear regression and the exponentiated demand equation
(Koffarnus, Franck, Stein, & Bickel, 2015; Strickland et al., in press; Equation 1):
Equation 1: 𝑄 = 𝑄0 ∗ 10𝑘∗(𝑒

(−𝛼∗𝑄0∗𝐶)

−1)

Where Q = consumption; Q0 = derived intensity of demand (consumption at zero price);
k = a constant that denotes the range of consumption values in log1 0 units (set to 4 for all
analyses); C = the price of the commodity; and α = derived essential value (a measure of
elasticity of demand). Greater values of Q0 indicate greater consumption at
unconstrained price (i.e., a theoretical price of zero). Greater values of α indicate a
higher elasticity of demand or change in consumption with change in unit price.
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Purchase task data have traditionally been modeled using the exponential demand
equation (Hursh & Silberburg, 2008; Equation 2):
Equation 2: log10 𝑄 = log10 𝑄0 + 𝑘 ∗ (𝑒 (−𝛼∗𝑄0∗𝐶) − 1)
However, recent evidence indicates that the exponentiated model provides a superior fit
because this model can incorporate zero consumption values without transformation
(Koffarnus et al., 2015; Strickland et al., in press). Given the relative novelty of the
exponentiated model, the exponential model was tested to verify the exponentiated
model’s superior fit. Zeros were replaced with an arbitrary non-zero number (0.01) for
the exponentiated model analysis, consistent with standard practice (Koffarnus et al.,
2015). Table 2.2 presents the timeline for all experimental tasks and procedures.
Data Analysis
Primary Outcomes: Loss Aversion as a Function of Risk and Commodity.
Standardized loss aversion coefficients (λ) were calculated for individual tasks as
described above. One-sample t-tests were used to determine if λ values differed from
the population normative value of 2. This value was selected because it is the typical λ
value observed in non-clinical (i.e., normative) populations (see Kahneman & Tversky,
1979; Novemsky & Kahneman, 2005; Tversky & Kahneman, 1992). This value also lies
within the range of values described by several meta-analyses on WTP/WTA disparities
(Neumann & Böckenholt, 2014; Sayman & Öncüler, 2005; Tunçel & Hammitt, 2014).
Loss aversion 95% confidence intervals were evaluated to determine the precision of the
present estimate and the margin of difference from the prototypic value of 2.
A follow-up analysis was conducted with valuation task data to determine if the
within-subjects manipulation presented a potential confound (e.g., carryover responding
from WTP to WTA or vice versa). This analysis closely resembles the methods used in
traditional valuation task studies in which each participant only completes one task (i.e.,
a between-subject manipulation). Data from the first task each participant completed
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were used and independent-samples t-tests conducted comparing WTA and WTP
values between groups. Median values for WTP and WTA were also used in this followup analysis to generate estimated λ values. Median values were used in this betweensubjects designs to account for potential distributional skew and/or outliers as described
previously (see Kahneman et al., 1990). A secondary analysis of mixed gambles data
was also conducted to determine the predicted probability of gamble acceptance at an
expected value of zero, as well as the expected value at which the predicted probability
of gamble acceptance was 50%. These values were determined using logistic
regression with expected value as the predictor and choice as the criterion.
A high proportion of participants (60.5%) indicated that the price range used for the
headphone valuation task was too restrictive and that they would sell or purchase the
headphones for more than $10.00. Given this potential methodological confound, only
the mug commodity was used for the remainder of analyses. The influence of risk and
commodity type on loss aversion was examined using a 2 x 2 ANOVA with Risk
(Riskless versus Risky) and Commodity (Non-Drug versus Drug) as the within-subjects
factors. Risk aversion and counterbalance order were included as covariates in
additional models to evaluate the influence of these potential confounds on study
outcomes. The effects of Risk and Commodity Type were also evaluated using linear
mixed-effects models in the lme4 package for R statistical software (Bates, Maechler,
Bolker, & Walker, 2015), with Risk, Commodity, and the Risk x Commodity interaction
defined as fixed, within-subjects factors and participant defined as a random factor. An
alternative approach of using difference scores (e.g., WTP – WTA) rather than ratios
was also explored. The outcomes of these analyses were not qualitatively different than
ratios, and therefore, for parsimony and comparison to the broader research literature,
only ratio analyses are reported. The relationship between λ values from valuation and
mixed-gambles tasks were analyzed using Spearman rank correlations. Non-parametric
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Spearman rank correlations were used for to help control type I and type II error rate
inflation due to non-normal variable distributions (Bishara & Hittner, 2012).
Secondary Outcomes: Individual Differences in Loss Aversion. Cocaine
purchase data were analyzed in GraphPad Prism 6.0f (GraphPad Software Inc.; La
Jolla, CA), as described above. Additional parameters, including intensity (consumption
at zero price), Omax (maximum amount of money allocated to cocaine purchase), P max
(price at which O max is achieved), and Breakpoint (first price at which consumption is
zero) were computed graphically (e.g., Amlung et al., 2015; MacKillop et al., 2008;
Murphy & MacKillop, 2006). All demand metrics were log-transformed to correct for a
high degree of skew. The relationship between derived intensity (Q0) and reported
consumption at zero price was used to evaluate model appropriateness. Multiple
regression models including gain and loss coefficients (e.g., WTP, WTA) and λ values
were used to evaluate the relationship between λ and purchase task and demographic
outcomes. The incremental validity of adding λ to models including components of the
ratio was determined and statistically significant increments in R2 interpreted using semipartial correlations. Spearman rank correlations were also used to determine if purchase
task metrics were associated with other drug use (e.g., DAST, monthly cocaine use) and
demographic (e.g., age, sex) variables. All ANOVAs and correlational analyses were
conducted in SPSS Statistics 22 (IBM; Armonk, NY) with a type I error rate of 0.05.
Power Analysis
An a priori power analysis was conducted to determine the sample size needed to
detect a medium effect size difference from 2 for λ (Cohen’s d = .50) using two-tailed
tests and a type I error rate of .05. This power analysis indicated that 38 participants
would be needed to detect this effect with 85% power.
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Table 2.1 Participant Demographics and Drug Use Variables

Age
Females
Race
Caucasian
African American
Years of Education
Income
ZKPQ
CPD
FTND
Alcoholic Drinks Per Week
MAST
DAST
Cocaine Use
Days Used Per Month
Money Spent Per Month
Lifetime Uses
Years Used

Mean

SD

45.7
16 (42%)

5.8

7 (18%)
31 (82%)
12.1
$7155
1.4
11.8
3.8
14.6
8.4
10.2

1.5
$7479
1.7
7.4
2.3
17.0
8.8
5.6

15.7
$659.5
3562.6
20.3

9.2
$701.0
2715.6
8.3

Note. ZKPQ = Impulsivity Subscale of the ZuckermanKuhlman Personality Questionnaire; CPD = cigarettes per day;
FTND = Fagerström Test for Nicotine Dependence; MAST =
Michigan Alcohol Screening Test; DAST = Drug Abuse
Screening Test.
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Table 2.2 Timeline for Experimental Procedures
Time

Experimental Activity

0h

Arrival

0 – 0.25 h

Sobriety Test, Urine Screen, Pre-Session Paperwork/Informed Consent

0.25 – 0.50 h

Traditional and Cocaine Valuation Tasks 1 (WTA/WTP)*

0.50 – 0.75 h

Traditional Mixed Gambles Task

0.75 – 1.00 h

Break

1.00 – 1.25 h

Cocaine Mixed Gambles Task

1.25 – 1.50 h
1.50 h

Traditional and Cocaine Valuation Tasks 2 (WTA/WTP)*
Risk Aversion and Cocaine Purchase Task
Participant Payment/Discharge

*Presentation of Willingness-to-Accept (WTA)/Willingness-to-Purchase (WTP) conditions
of valuation tasks counterbalanced across participants
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Chapter 3: Results
Valuation Task Performance
Means and standard deviations for WTP, WTA, and λ values on the headphone,
mug, and cocaine valuation tasks are presented in Table 3.1. Similar magnitude prices
for selling (WTA) and buying (WTP) conditions were observed for all commodities, as
indicated by an average λ of approximately 1 (Headphones = 1.04; Mug = 1.15; Cocaine
= 1.14). One-sample t-tests showed that λ values for all commodities were significantly
lower than a standard value of 2, t37 values > 6.95, p values < .001, d values > 1.13 (see
Table 3.1).
Follow-up analysis analogous to the methods used in traditional valuation task
studies (i.e., using only data from the first task completed by each participant) supported
the conclusions from the within-subjects comparisons. Specifically, independentsamples t-tests did not reveal statistically significant differences in prices for selling and
buying conditions for the three commodities, Headphones: t36 = 0.77, p = .45; Mug: t36 =
0.69, p = .49; Cocaine: t36 = 0.61, p = .55. Similar magnitude λ scores as the withinsubjects data were also observed when using WTA and WTP values from this first task
only subset (λ: Headphones = 0.83; Mug = 1.20; Cocaine = 1.17).
Mixed Gambles Task Performance
Means and standard deviations for λ on the mixed gambles task as well as gain and
loss coefficients are presented in Table 3.2. Participants were, on average, equally
sensitive to the magnitude of loss and gain as reflected by mean λ values of
approximately 1 (Money Task = 0.99; Cocaine Task = 1.08). One-sample t-tests
supported this conclusion by indicating a statistically significant difference from a λ of 2
for money, t32 = 8.82, p < .001, d = 1.53, and cocaine, t30 = 8.63, p < .001, d = 1.55.
Excluded participants reported more frequent cocaine use (22 versus 14 average
days per month, t36 = 2.38, p = .02) and higher nicotine dependence scores (5.3 versus
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3.4 average FTND, t3 6 = 2.47, p = .02), but did not differ on other demographic and drug
use variables. Additionally, included and excluded participants did not differ on loss
aversion values generated from the valuation tasks, Headphones: t3 6 = 0.29, p = .77;
Mug: t36 = 0.42, p = .68; Cocaine: t36 = 0.09, p = .93.
A secondary analysis of mixed gambles data indicated that the average predicted
probability of gamble acceptance at an expected value of zero was 38.9% for cocaine
and 30.8% for money. The expected value at which the predicted probability of gamble
acceptance was 50% for the monetary and cocaine mixed gambles task was, on
average, $3.5 and 0.0 grams cocaine, respectively.
Loss Aversion by Risk and Commodity Condition
Figure 3.1 displays λ values as a function of risk and commodity type. All 95%
confidence intervals did not overlap with the normative value of 2 and indicated estimate
precision as evidenced by tight interval width. A 2 x 2 ANOVA did not reveal a
statistically significant main effect of Risk, F1,28 = 1.66, p = .21, ηp 2 = .06, main effect of
Commodity, F1,28 = 0.05, p = .83, ηp 2 < .01, or Risk x Commodity interaction, F 1,28 = 0.64,
p = .43, ηp2 = .02. Counterbalance order and risk aversion did not impact these
relationships as indicated by the lack of statistically significant main effects or
interactions when included in the model. Similar results were observed when using linear
mixed-effects models, with no statistically significant effects of Risk, p = .29, Commodity,
p = .95, or Risk x Commodity interaction, p = .63. Loss aversion coefficients were also
not significantly correlated with risk aversion, Mug Valuation: rsp < .01, p = .98; Cocaine
Valuation: rsp = .14, p = .41; Traditional Gambles: rsp = .08, p = .65; Cocaine Gambles: rsp
= .19, p = .28.
Figure 3.2 contains individual participant data from the valuation task (circles) and
mixed gambles task (squares). Individual data matched the group-averaged analyses
well. Tight clustering was observed around mean values with few values deviating from
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this central tendency (SDs: Non-Drug Valuation = 0.75; Drug Valuation = 0.58; Non-Drug
Mixed Gambles = 0.66; Drug Mixed Gambles = 0.59). Furthermore, few participants
exhibited loss aversion scores greater than 2 (~2-3 participants per task).
Spearman correlations among loss aversion coefficients revealed two statistically
significant associations. Higher loss aversion values on the mug valuation task were
associated with higher values on the cocaine valuation task, r = .33, p = .04. In contrast,
lower loss aversion values on the cocaine valuation task were associated with higher
loss aversion on the monetary mixed gambles task, r = -.43, p = .01. All other
associations were not statistically significant, Mug-Monetary Gambles: r = .08; MugCocaine Gambles: r = .04; Cocaine Valuation-Cocaine Gambles: r = .16; Monetary
Gambles-Cocaine Gambles; r = .31.
Individual Differences in Loss Aversion
Table 3.3 contains associations between loss aversion outcomes and demographic
and drug use variables. Mixed gambles λ values for both commodities were associated
with self-reported days of past month cocaine use. Monetary gambles λ values were
negatively associated with past month cocaine use. In contrast, cocaine gambles λ
values were positively associated with past month cocaine use. Mug valuation λ values
were also positively associated with self-reported alcoholic drinks per week. No other
correlations between loss aversion and demographic and drug use variables were
statistically significant.
Cocaine Purchase Task
One participant’s data were non-systematic and removed from data analysis due to
poor demand fit (R2 = .25). Figure 3.3 shows the exponentiated model fit to mean
cocaine demand (left) as well as the mean expenditure at each price (right). This model
provided an excellent fit to mean consumption data (R2 = .99) as well as individual
consumption data (Mean R2 = .93; SD = .05). Fits from the exponentiated model were
28

superior to the exponential model (Mean R2 = .79; SD = .09) and this difference was
statistically significant, t35 = 9.99, p < .001, dz = 1.66. The correlation between derived
(i.e., Q0) and reported intensity of demand (i.e., consumption at free price) was also
stronger for the exponentiated model, r = .89, than exponential model, r = .81, although
both associations were statistically significant.
Table 3.4 contains means and standard deviations for cocaine purchase task
outcomes and Table 3.5 contains associations between demand outcomes and loss
aversion values. Cocaine λ values on the mixed gambles task were positively related to
demand intensity and negatively related to demand elasticity. Cocaine λ values on the
valuation task were positively related to breakpoint. Demand metrics were not
significantly related to non-drug valuation or monetary mixed gambles outcomes.
Table 3.6 contains correlations between these demand parameters and demographic
and drug use variables. Derived and graphical demand intensity were positively related
to days of cocaine use and money spent on cocaine per month as well as DAST scores.
Omax and Pmax scores were also positively related to cigarette use variables. No other
correlations were statistically significant.
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Table 3.1 Loss Aversion Scores for Valuation Tasks

Commodity

WTA
Mean
SD

WTP
Mean
SD

Mean

Lambda (λ)
SD
t

Headphones

$7.05

$2.68

$7.55

$2.66

1.04*

0.50

11.83

1.92

Mug

$3.14

$1.74

$3.14

$1.81

1.15*

0.75

6.95

1.13

Cocaine

$75.26

$33.67

$70.00

$24.82

1.14*

0.58

9.10

1.48

d

Note. WTA = Willingness-to-Accept; WTP = Willingness-to-Purchase. * p < .001 comparing
λ to a value of 2.
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Table 3.2 Loss Aversion Scores for Mixed Gambles Tasks
Loss Coefficient

Gain Coefficient

Lambda (λ)

Commodity

Mean

SD

Mean

SD

Mean

SD

Money

-0.43

0.24

0.53

0.29

0.99*

0.66

Cocaine

-0.49

0.32

0.48

0.28

1.08*

0.59

Note. * p < .001 comparing λ to a value of 2.
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Table 3.3 Semi-Partial Correlations Between Loss Aversion, Demographics, and Drug Use
Cigarette Use
Riskless
Mug- λ
Cocaine- λ
Risky
Money- λ
Cocaine- λ

Alcohol Use
Drinks/
Week
MAST

Age

Male

ZKPQ

Income

DAST

CPD

FTND

.18
.04

-.18
.15

.15
.02

.15
-.11

-.13
.12

-.01
-.26

-.10
-.28

.41*

-.01
-.01

.31
-.15

-.07
.11

-.26
-.20

-.13
.13

-.31
-.20

-.19
.01

Cocaine Use
Days/ Money/
Month
Month

.04

-.10
.07

.14
.18

-.05
.14

.01
.03

.16
-.04

-.38*
.41*

-.07
.11
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Note. WTA = Willingness-to-Accept; WTP = Willingness-to-Purchase; Income = Yearly Income; ZKPQ = Impulsivity
Subscale of the Zuckerman-Kuhlman Personality Questionnaire; DAST = Drug Abuse Screening Test; CPD =
cigarettes per day; FTND = Fagerström Test for Nicotine Dependence; MAST = Michigan Alcohol Screening Test.
Semi-partial correlations controlled for gain and loss constituents of the λ ratio. Bold = statistically significant
correlation.
*p < .05; **p < .01

Table 3.4 Primary Outcomes on the Cocaine Purchase Task
Outcome

Mean

SD

Intensity

50.1

57.9

Omax

$516.4

$900.2

Pmax

$54.4

$165.5

Breakpoint

$156.9

$273.2

Elasticity

.0036

.0089

Q0

47.2

58.9

R2

.93

.05

Note. Elasticity and Q0 fit
exponentiated demand model.

using

the
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Table 3.5 Semi-Partial Correlations Between Cocaine Demand and Loss Aversion
Outcomes

Riskless
Mug-λ
Cocaine-λ
Risky
Money-λ
Cocaine-λ

Intensity

Omax

Pmax

Breakpoint

Elasticity

Q0

<.01
.19

-.20
.25

-.24
.30

-.14
.36*

.01
-.20

-.07
-.05

.08
.42*

-.20
.28

-.18
-.03

-.18
.19

.28
-.45*

.14
.38*

Note. Semi-partial correlations controlled for gain and loss constituents of the λ
ratio. All demand metrics were log-transformed prior to analysis. Bold =
statistically significant correlation.
*p < .05; **p < .01
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Table 3.6 Spearman Correlations Between Demand Outcomes, Demographics, and Drug Use
Cigarette Use

Intensity
Omax
Pmax
Breakpoint
Elasticity
Q0

Age
.04
.17
.27
.22
.06
.11

Male
.20
.13
-.11
.07
-.17
.14

Income ZKPQ
-.11
.08
.03
.30
.19
.22
.29
.26
.01
-.17
-.21
-.09

DAST
.43**
.05
-.13
-.05
.05
.37*

CPD
.26
.35*
.17
.30
-.16
.16

FTND
.09
.31
.35*
.25
-.04
.08

Alcohol Use
Drinks/
Week
MAST
.09
-.05
.01
.02
-.15
-.05
-.13
-.02
-.16
.06
.17
-.02

Cocaine Use
Days/ Money/
Month
Month
.48**
.63**
.24
.31
-.15
-.01
-.03
.16
-.22
-.20
.44**
.51**
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Note. Income = Yearly Income; CPD = cigarettes per day; ZKPQ = Impulsivity Subscale of the Zuckerman-Kuhlman
Personality Questionnaire; DAST = Drug Abuse Screening Test; FTND = Fagerström Test for Nicotine Dependence;
MAST = Michigan Alcohol Screening Test. All demand metrics were log-transformed prior to analysis. Bold =
statistically significant correlation.
*p < .05; **p < .01

Figure 3.1 Loss aversion coefficients for valuation (black bars) and mixed gambles
(white bars) tasks. Data represented from all included participants on each task (n = 31
to 38). Bars represent mean values and error bars represent 95% confidence intervals.
Dotted line is placed at the normative loss aversion value of 2.
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Figure 3.2 Individual participant data from valuation (circles) and mixed gambles
(squares) tasks. Data represented from all included participants on each task (n = 31 to
38). Means represented by solid horizontal lines in each column of data. Dotted line is
placed at the normative loss aversion value of 2.
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Figure 3.3 Economic demand for cocaine in active cocaine users (n = 37). Participants
completed a cocaine purchase task in which hypothetical cocaine (0.1 g) was available.
Price varied in United States dollars (USD) and hypothetical consumption measured. On
the left is reported consumption plotted as mean (SD) group data on a log-linear axis fit
using the exponentiated model (Equation 1 shown in the Methods). On the right is
reported expenditure plotted as mean (SD) group data.
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Chapter 4: Discussion
The purpose of the present study was to evaluate loss aversion in active cocaine
users. Cocaine users showed a robust and reliable reduction in loss aversion when
compared to standard values obtained in the general population. This difference was
observed across multiple tasks designed to evaluate loss aversion under conditions of
certainty and conditions of risk. Attenuated loss aversion was also consistent across
commodities, including non-drug (e.g., money) and hypothetical drug (e.g., cocaine)
commodities. Hypothetical demand for cocaine decreased with increases in price and
this relationship was well explained by mathematical models of demand. More intense
and inelastic cocaine demand was associated with greater loss aversion for cocaine.
These data represent the first comprehensive study on multiple dimensions of loss
aversion in a substance using population and suggest that reductions in loss aversion
are associated with a history of cocaine use.
Participants reported similar sensitivities to gains and losses across conditions of
certainty and risk as well as for drug and non-drug commodities. This absence of loss
aversion, as indicated by λ values of 1, was remarkably consistent across all
experimental conditions. These results are even more striking considering that
inspection of individual data revealed few exceptions to this trend. Equally important to
note is that the absence of loss aversion could not be attributed to the study’s withinsubjects design. A between-subject analysis using only data from the first task
completed did not reveal statistically significant differences in the prices for selling and
buying conditions. This analysis also indicated λ values similar to the within-subject
comparison. This consistency is important because between-subjects manipulations
analogous to this between-subject analysis are traditionally used to generate WTP,
WTA, and λ values with valuation tasks (e.g., Kahneman et al., 1990; Novemsky &
Kahneman, 2005).
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A uniform response to gains and losses stands in direct contrast to the rich
behavioral economic literature demonstrating that losses generally have a greater
impact on behavior than gains (Kahneman & Tversky, 1979; Morewedge & Giblin, 2015;
Tversky & Kahneman, 1991, 1992). The established 2:1 sensitivity of losses to gains (λ
= 2) has been observed across a variety of experimental conditions, including the
valuation and mixed gambles tasks used here (e.g., Gachter et al., 2007; Kahneman et
al., 1990; Tom et al., 2007). Although controls were not explicitly recruited in the current
study, comparison of the observed λ values to this normative and accepted value of 2 in
the general population revealed statistically significant differences that were large in
effect size. The robust nature of this difference combined with the consistency across
and within experimental conditions provides convincing evidence for an attenuation of
loss aversion in this cocaine-using population.
Reliable correlations among measures of loss aversion were not observed. In fact,
loss aversion for cocaine on the valuation task was negatively correlated with loss
aversion for money on the mixed gambles task. Analysis of individual data revealed a
high degree of homogeneity and clustering for λ values on each loss aversion task. It is
possible that a low degree of variability resulted in range restriction and attenuation for
the observed associations. Follow up studies could address this concern by recruiting
individuals with more varied drug use and explore the relationship between loss aversion
and different translational stages of cocaine misuse (e.g., recreational use, dysregulated
use, abstinence, relapse, and recovery) or by studying individuals who report use of
other drugs (e.g., opioids or cannabis).
Economic demand for cocaine was effectively and efficiently measured using a
hypothetical cocaine purchase task. Demand for cocaine systematically decreased with
increases in price and was well explained by the exponentiated demand equation for a
majority of participants (97.4%). The exponentiated model has recently been introduced
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as an alternative to the typically used exponential model because it can incorporate the
zero consumption values commonly observed with human purchase task data (whereas
the exponential model cannot; Koffarnus et al., 2015; Strickland et al., in press). The
current experiment provides additional support for the utility of the exponentiated model
by demonstrating superior demand fit and association between self-reported and modelderived measures of demand intensity. Cocaine demand parameters were also
associated with measures of cocaine use (e.g., days used cocaine per month),
consistent with other studies using alcohol and cigarette purchase tasks. These findings
lend additional support for the construct validity of purchase task techniques for
measuring cocaine use. Future research will be needed to evaluate the predictive
validity of this measure for evaluating behavioral and pharmacological interventions for
cocaine use disorder.
More inelastic and intense cocaine demand was associated with greater loss
aversion for cocaine on the mixed gambles task. Higher breakpoints were also
associated with greater loss aversion on the cocaine valuation task. Relatedly, more
frequent cocaine use was associated with higher loss aversion for cocaine and lower
loss aversion for money on the mixed gambles tasks. These results collectively indicate
that problematic cocaine use is positively associated with loss aversion for drug and
negatively associated with loss aversion for non-drug commodities. This finding is
consistent with the idea that problematic and prolonged substance use involves an
increased focus on drug consumption coupled with a decreased attention to the negative
consequences caused by that use (i.e., the loss of non-drug commodities; American
Psychiatric Association, 2013). Future studies will be needed to further evaluate the
association between drug demand, loss aversion, and traditional measures of drugtaking behavior to replicate and clarify these relationships.
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The current findings are congruent with the results of prior studies on loss aversion
conducted in illicit drug users (e.g., Ahn et al., 2014; Fridberg et al., 2010; Vassileva et
al., 2013). These studies have generally reported outcomes consistent with decreases in
loss aversion by using computational modeling combined with IGT data. In one such
study, chronic cannabis users showed attenuated loss aversion on the IGT relative to
matched controls (Fridberg et al., 2010). Similar outcomes were reported in a later study
with heroin-dependent patients in extended abstinence (> 3 months; Ahn et al., 2014).
Most studies in cocaine users also report findings suggestive of decreases in loss
aversion that are consistent with the present finding (Stout et al., 2004; Vassileva et al.,
2013). For example, drug use in a sample of HIV-positive women (that included a subset
of individuals reporting cocaine use) was associated with diminished loss aversion on
the IGT (Vassileva et al., 2013). It is important to note that the above findings were
collected with an indirect measure of loss aversion (i.e., computational modeling of IGT
performance) that is not traditionally used in behavioral economic research. This
discrepancy makes comparisons to the broader behavioral economic literature difficult. A
study presented at the 2014 annual meeting of the College on Problems of Drug
Dependence reported enhanced loss aversion in HIV-positive cocaine users on a task
similar to the mixed gambles task used here (Meade et al., 2014). The reasons for the
discordance between these findings and the present study are not known; however, it is
possible that HIV comorbidity in this other sample influenced the experimental
outcomes. It is also important to recognize that these findings have not been published
in a peer-reviewed format and only represent a preliminary data analysis. Thus, the
results from the majority of previous research in substance using populations coupled
with the present findings suggest that drug use is associated with the decreased and
possible absence of loss aversion.
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A review of laboratory studies conducted in other clinical populations offers several
behavioral and neurobiological mechanisms that may underlie the absence of loss
aversion observed in cocaine users. Problem gamblers, for example, have generally
shown similar decreases in loss aversion (Brevers et al., 2012; Lorains et al., 2014; but
see Giorgetta et al., 2014). These decreases have been reported in non-treatment
seeking gamblers (Brevers et al., 2012) as well as those in outpatient treatment (Lorains
et al., 2014). High rates of comorbidity are observed between problem gambling and
substance use, with some suggesting that dysregulation in impulsive behavior is the
common trait underlying these disorders (Lorains, Cowlishaw, & Thomas, 2011; Peters
et al., 2015; Verdejo-Garcia, Lawrence, & Clark, 2008). It is possible that changes in
impulsive behavior also represent the behavioral mechanism underlying the decreased
loss aversion observed in these populations. Although the relationship between
impulsive behavior and loss aversion has not been extensively examined, preliminary
evidence obtained in adolescents suggests that higher rates of impulsivity are
associated with decreases in loss aversion (Ernst et al., 2014). A correlation between
loss aversion and the impulsivity subscale of the ZKPQ was not observed in this study.
Self-report measures like the ZKPQ likely reflect broader indicators of trait personality
rather than specific and individual types of impulsive behavior (de Wit, 2009; Reynolds,
Ortengren, Richards, & de Wit, 2006). These measures also require the participant to
accurately assess behavior over a variety of situations and typically only show modest
correlation with more direct behavioral measures (Cyders & Coskunpinar, 2011; de Wit,
2009; Reynolds et al., 2006). The use of methods that examine specific behavioral
constructs of impulsive behavior (e.g., delay discounting; response inhibition) in future
studies will be important for evaluating the functional relationship between impulsivity
and loss aversion.
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Reductions in loss aversion are also consistently observed in individuals with
schizophrenia (Brown et al., 2013; Kim, Kang, & Lim, 2016; Tremeau et al., 2008). For
example, patients with schizophrenia have failed to show loss aversion in a valuation
task similar to the one used here (λ = 0.87; Tremeau et al., 2008). Individuals with
schizophrenia also show impaired assessment of expected value on a mixed gambles
task (Brown et al. 2013). Dopaminergic theories of schizophrenia posit that dysfunction
in presynaptic dopaminergic terminals contributes to the development and persistence of
the disorder (see review by Howes, McCutcheon, & Stone, 2015). Chronic cocaine use
also results

in functional alterations

in the

dopaminergic

system, including

downregulation of dopamine D 2 receptors and a hypo-dopaminergic state (Goldstein et
al., 2010; Volkow et al., 1996). Disrupted and aberrant signaling in the dopamine system
could represent a neurobiological mechanism mediating decreased loss aversion. In
fact, neuroimaging research suggests that regions in the mesolimbic dopamine system
play a role in loss aversion (Tom et al., 2007). Participants in that study completed a
mixed gambles task while fMRI techniques were used to evaluate the neural systems
activated during gains and losses. It was found that loss anticipation produced
deactivation in mescorticolimibic structures and that this diminished neural sensitivity
was associated with decreased loss aversion. Recent evidence that links functional
polymorphisms in BDNF and ANKK1 genes to changes in loss aversion also supports
this dopamine hypothesis (Voigt, Montag, Markett, & Reuter, 2015). Specifically,
participants in that study with polymorphisms related to decreased BDNF secretion and
D2 receptor density and binding reported the lowest loss aversion scores. Follow-up
studies are needed to test this dopamine hypothesis because similar behavioral
phenotypes (e.g., reduced loss aversion) may arise from distinct neurobiological
mechanisms. Pharmacological manipulations directly targeting the dopaminergic system
(e.g., acute amphetamine and/or haloperidol challenge) and additional neuroimaging
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studies evaluating both structure and function in combination with behavior could help
elucidate the role of dopamine in mediating the expression of loss aversion.
Loss aversion has also been implicated in limbic system function and, in particular,
amygdala activity. For example, damage to the amygdala abolishes behavioral
expression of loss aversion under risky conditions (De Martino et al., 2010). In that
study, two patients with focal bilateral amygdala lesions completed a mixed gambles
task and performance compared to matched controls. Dramatic attenuation of loss
aversion was observed in these patients despite no differences in risk aversion or
expected value computation (i.e., preference for larger gains and smaller losses). Loss
aversion on mixed gambles tasks is also associated with differential amygdala activity
following losses and gains in healthy participants (Sokol-Hessner, Camerer, & Phelps,
2013). Participants in that study were healthy, college students who completed a mixed
gambles task combined with fMRI. Greater BOLD activity in the amygdala in response to
losses relative to gains was associated with greater expression of loss aversion (i.e.,
higher λ values).
These findings suggest a potential arousal mechanism involved in loss aversion
given the role that the amygdala and the greater limbic structures play in regulating
arousal and emotion. Support for this hypothesis comes from skin conductance studies
that have demonstrated greater autonomic response to losses than gains and that these
differences are positively associated with loss aversion (i.e., greater autonomic response
to loss than gain is correlated with greater loss aversion; Sokol-Hessner et al., 2009;
Wu, Van Dijk, Aitken, & Clark, 2016). An autonomic arousal mechanism is also
supported by a recent study in which administration of the β-adrenergic receptor
antagonist propranolol reduced loss aversion, but had no effect on risk sensitivity or
choice consistency (Sokol-Hessner et al., 2015). Awareness of one’s arousal also likely
contributes to loss aversion because interoception (i.e., sensitivity to internal
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physiological states) positively correlates with loss aversion (Sokol-Hessner, Hartley,
Hamilton, & Phelps, 2015). In that study, performance on a heartbeat-detection task
used to measure interoceptive ability was positively correlated with loss aversion on a
mixed gambles task. Interoceptive performance was not associated with risk response or
choice consistency indicating that the relationship was specific to loss aversion.
The association between interoception, limbic system function, and loss aversion is
notable given recent arguments that addictive behaviors are functionally tied to
dysregulated interoceptive activity, deficits in arousal, and disrupted activity in the insular
cortex (see reviews by Paulus & Stewart, 2014; Paulus, Tapert, & Schulteis, 2009).
Cocaine use is related to changes in amygdala structure and function, including
decreases in overall volume and binding potential (e.g., Makris et al., 2004; Milella et al.,
2014). More broadly, cocaine use is associated with decreases in mesocorticolimbic
system volume and reduced functional connectivity among system circuits (e.g., Gu et
al., 2010; Hu, Salmeron, Gu, Stein, & Yang, 2015; Rando, Tuit, Hannestad, Guarnaccia,
& Sinha, 2013). Few studies have systematically examined interoception in cocaine
users, but some data exists suggesting compromised interoceptive awareness and
alterations in the structure and function of the insular cortex (e.g., Cisler et al., 2013;
Ersche et al., 2014; Stewart, Juavinett, May, Davenport, & Paulus, 2015). More work is
needed, however, to understand possible changes in interoceptive awareness among
cocaine users and how these changes might relate to loss aversion.
Several limitations of the current study should be noted. First, these data represent a
cross-sectional analysis of loss aversion in current cocaine users. Longitudinal studies
are necessary for differentiating those effects that are antecedent to and those that are a
consequence of cocaine use. Such findings will help determine if loss aversion
represents a predisposing/risk factor for developing a cocaine use disorder or is a result
of a history of cocaine use (or, most likely, a combination of the two). Such a distinction
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is crucial for determining to what extent loss aversion may provide a behavioral marker
for substance use diagnosis and assessment.
Second, comparisons between the monetary and cocaine mixed gambles tasks
should be made with caution because the ranges of gains and losses, outcomes of
decisions (i.e., real versus hypothetical), and qualitative nature of the commodities (i.e.,
dollars versus grams) were different. Of particular note, a recent study found that the
gain and loss ranges used on mixed gambles tasks can influence the derived loss
aversion coefficient (Walasek & Stewart, 2015). Participants in that study were randomly
assigned to complete mixed gambles tasks with varying distributions of gains and
losses. Discrepant loss aversion outcomes were observed with each of these range
conditions, including the expression of loss aversion, absences of loss aversion, and
reverse of loss aversion (λ < 1). The gain and loss ranges used in the present study
were identical to a range that produced loss aversion in the aforementioned study (λ =
1.93; Walasek & Stewart, 2015) as well as other demonstrations of loss aversion in
healthy participants (λ = 1.93; Tom et al., 2007). Thus, it is unlikely that the lower loss
aversion observed on the mixed gambles task was due to this methodological variable.
Third, it is unclear how loss aversion might relate to other behavioral mechanisms
implicated in substance use disorders. The current study evaluated economic demand
for cocaine, but did not include other common principles studied in the behavioral
economic and substance use literatures (e.g., delay discounting, status quo bias;
Chivers & Higgins, 2012). As noted above, a rich body of literature has demonstrated the
relationship between drug use and delay discounting (Bickel et al., 2012). It is possible
that loss aversion and delay discounting represent related behavioral phenomenon that
are similarly related to substance use disorders. However, it is also possible that these
principles represent non-overlapping constructs that uniquely predict drug use. Future
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research could include additional behavioral economic measures in order test such
predictions.
Fourth, a substantial proportion of data were excluded from the mixed gambles task
due to the inability to effectively generate loss aversion coefficients. Model convergence
was not possible or stable in many of these cases due to the high proportion of gambles
accepted by some participants (e.g., acceptance of all or nearly all gambles). High rates
of gamble acceptance could be indicative of confusion about the task and its outcomes.
Alternatively, these data could indicate extreme loss aversion (or lack thereof) in which
any loss, no matter how large or small, is ineffective at changing behavior. Supporting
this hypothesis, excluded participants reported higher rates of cocaine use and greater
nicotine dependence. Additional comparisons made using linear mixed-effects models
that allowed for inclusion of participants with missing data did not result in qualitatively
different outcomes. Analysis of data from the valuation tasks also indicated that these
excluded participants did not differ on WTA, WTP, or λ values meaning that their
exclusion from some analyses was unlikely to have systematically biased study
outcomes.
Finally, it is possible that changes in loss aversion are epiphenomenally related to
other primary causal agent(s) implicated in substance use disorders. For example,
socioeconomic status (SES) is frequently tied to drug use and other adverse health
behaviors (Galea & Vlahov, 2002; Gilman, Abrams, & Buka, 2003). Although few studies
have systematically studied the relationship between loss aversion and SES, the existing
literature suggests that lower SES is correlated with lower loss aversion (Gachter et al.,
2007). Participants in the present sample reported a mean yearly income that was below
the poverty threshold (Mean = $7155/year), however, income was not related to the
magnitude of loss aversion. It is possible that differences in SES between populations
rather than within this population might explain the lower loss aversion observed relative
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to individuals typically sampled in loss aversion studies (e.g., undergraduate and
graduate-level college students). Future studies will be needed to evaluate SES and
other alternative explanations for the relationship between loss aversion and substance
use.
Loss aversion could provide important translational implications for treatment and
interventions development. If loss aversion represents a behavioral mechanism
underlying the disadvantageous choices characteristic of substance use disorders, then
altering this bias could result in reciprocal changes in drug-taking behavior. This
possibility is not unwarranted given that loss aversion is sensitive to cognitive-regulation
strategies (Sokol-Hessner et al., 2009). For example, participants who engage in a
regulation strategy that emphasizes choices in isolation show greater loss aversion than
those engaged in a strategy that emphasizes choices in a broader setting (SokolHessner et al., 2009). Incorporating cognitive strategies designed to change loss
aversion in the context of other interventions, such as cognitive-behavioral therapy,
might provide an efficient means to modify drug-taking behavior.
Loss aversion is also closely tied to CM and the framing of incentives as gains or
losses. Reinforcers delivered in CM may be framed as either a gain contingent on the
presence of a desired behavior (e.g., positive reinforcement) or as a loss due to the
absence of a desired behavior (e.g., negative reinforcement; contract based
approaches). The present findings suggest a uniform sensitivity to loss and gain that
may make both forms of incentive framing in CM equally effective. Additional tests are
needed to determine if loss aversion may provide a putative moderator of CM efficacy
and allow for patient-level tailoring of CM designs.
Prospect theory and loss aversion were first introduced to explain deviations from
traditional economic theory and the idea that a rational decision maker makes decisions
based on expected utility. Participants in the present study unexpectedly operated under
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conditions more closely aligned with an expected utility hypothesis than the “irrational”
agent described by prospect theory. The reported loss aversion values (i.e., ) of one
suggest an equal sensitivity to losses and gains (i.e., loss equivalence) that is predicted
by an expected utility model of choice. For example, decisions in the mixed gambles
task approximated decision-making based on expected utility (e.g., indifference at an
expected value of zero). That cocaine users displayed rational economic choice is
consistent with the growing body of literature challenging the assumption that individuals
with substance use disorders exhibit extensive cognitive impairment and uncontrollable,
irrational behavior (e.g., Hart, Marvin, Silver, & Smith, 2012). Decisions based on
expected utility and made with a proportional weight given to gains and losses are often
desirable and advantageous (e.g., in market trading, investing, gambling). However, loss
equivalence may also decrease the appropriate attention needed to harmful
consequences that loss aversion may otherwise protect against (e.g., the decision to use
drugs despite the negative health, social, and/or economic consequences). It is possible
that this inattention contributes to the impaired insight into drug use and need for
treatment that often impede intervention efforts in substance-using populations.
Addressing loss aversion in this respect may help improve awareness and evaluation of
the negative consequences of drug use to encourage treatment-seeking behavior and
improve retention in existing interventions.
The current findings expand the extant literature on the intersection of behavioral
economics and addiction science by using multi-method, within-subjects techniques to
study loss aversion in cocaine users. There have been no studies conducted using the
valuation task in substance-using populations. Similarly, no studies have used the
ecological relevant commodity of abused drugs when examining loss aversion. Reliable
and robust evidence for decreased loss aversion in cocaine users was observed and
several behavioral and neurobiological mechanisms consistent with these results were
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identified. Research examining these putative mechanisms and the functional
relationship between loss aversion and drug-taking behavior will be crucial for the future
of loss aversion in directing treatment and interventions development efforts.
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